Filter by
- (-) Algeria (2)
- (-) Cote d'Ivoire (1)
- Angola (2)
- Benin (2)
- Botswana (3)
- Burkina Faso (4)
- Burundi (5)
- Cabo Verde (4)
- Cameroon (2)
- Central African Republic (1)
- Chad (2)
- Democratic Republic of the Congo (4)
- Equatorial Guinea (2)
- Eritrea (1)
- Eswatini (2)
- Ethiopia (6)
- Gabon (1)
- Gambia (3)
- Ghana (3)
- Guinea (3)
- Guinea-Bissau (1)
- Kenya (5)
- Lesotho (1)
- Malawi (1)
- Mali (2)
- Mauritania (1)
- Mauritius (4)
- Mozambique (9)
- Namibia (3)
- Niger (10)
- Nigeria (3)
- Rwanda (5)
- Sao Tome and Principe (1)
- Senegal (3)
- Sierra Leone (3)
- South Africa (1)
- South Sudan (2)
- Uganda (4)
- United Republic of Tanzania (4)
- Zambia (1)
- Zimbabwe (2)
- Codes not specific to health (2)
- Health and care workforce (7)
- Health facilities, service delivery (2)
- Health Information Systems (3)
- Health Insurance, Social Protection (10)
- (-) Health products (3)
- Institutions and mandate (8)
- Protection of specific groups (2)
- Public Health (6)
- Social determinants of health (2)
- Specific health area or disease (2)
Décret exécutif No 21-224 du 12 Chaoual 1442 fixant les modalités d’établissement de la liste des médicaments essentiels
The decree provides the modalities for establishing the list of essential medicines. It was published in the Official Journal of 31 May 2021 (pages 12 -13).
Arrêté du 11 Joumada El Oula 1442 fixant la procédure de fixation des prix des médicaments par le comité économique intersectoriel des médicaments
The order of 11 Joumada El Oula 1442 corresponding to 26 December 2020 lays down the procedure for setting the prices of medicinal products by the intersectoral economic committee for medicinal products. The text of this order was published in the official journal of 27 December 2020 (see pages 33-36).
Loi N° 2017-541 du 3 août 2017 relative à la régulation du secteur pharmaceutique
The objective of the law is to establish an institutional framework for regulating the pharmaceutical sector to ensure market approval and use of pharmaceutical products that are accessible, safe, efficient, and of appropriate quality (art.2). It notably establishes the Authority for pharmaceutical regulation (Autorité Ivoirienne de Regulation Pharmaceutique - AIRP) and addresses its mandates (chapter 1).